Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.46 EUR
163.09 M EUR
1.85 B EUR
299.54 M
About SANTEN PHARMACEUTICAL CO
Sector
CEO
Takeshi Ito
Headquarters
Osaka
Website
Founded
2016
ISIN
JP3336000009
FIGI
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SZD is 10.50 EUR — it has increased by 2.02% in the past 24 hours. Watch SANTEN PHARMACEUTICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange SANTEN PHARMACEUTICAL CO LTD stocks are traded under the ticker SZD.
SZD stock hasn't changed in a week, the month change is a −6.48% fall, over the last year SANTEN PHARMACEUTICAL CO LTD has showed a 24.26% increase.
We've gathered analysts' opinions on SANTEN PHARMACEUTICAL CO LTD future price: according to them, SZD price has a max estimate of 15.97 EUR and a min estimate of 10.44 EUR. Watch SZD chart and read a more detailed SANTEN PHARMACEUTICAL CO LTD stock forecast: see what analysts think of SANTEN PHARMACEUTICAL CO LTD and suggest that you do with its stocks.
SZD stock is 3.96% volatile and has beta coefficient of 0.36. Track SANTEN PHARMACEUTICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is SANTEN PHARMACEUTICAL CO LTD there?
Today SANTEN PHARMACEUTICAL CO LTD has the market capitalization of 3.59 B, it has decreased by −0.86% over the last week.
Yes, you can track SANTEN PHARMACEUTICAL CO LTD financials in yearly and quarterly reports right on TradingView.
SANTEN PHARMACEUTICAL CO LTD is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
SZD earnings for the last quarter are 0.15 EUR per share, whereas the estimation was 0.14 EUR resulting in a 7.37% surprise. The estimated earnings for the next quarter are 0.15 EUR per share. See more details about SANTEN PHARMACEUTICAL CO LTD earnings.
SANTEN PHARMACEUTICAL CO LTD revenue for the last quarter amounts to 447.59 M EUR, despite the estimated figure of 466.27 M EUR. In the next quarter, revenue is expected to reach 465.35 M EUR.
SZD net income for the last quarter is 50.86 M EUR, while the quarter before that showed 61.67 M EUR of net income which accounts for −17.53% change. Track more SANTEN PHARMACEUTICAL CO LTD financial stats to get the full picture.
As of Nov 22, 2024, the company has 3.74 K employees. See our rating of the largest employees — is SANTEN PHARMACEUTICAL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANTEN PHARMACEUTICAL CO LTD EBITDA is 436.12 M EUR, and current EBITDA margin is 23.21%. See more stats in SANTEN PHARMACEUTICAL CO LTD financial statements.
Like other stocks, SZD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANTEN PHARMACEUTICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SANTEN PHARMACEUTICAL CO LTD technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SANTEN PHARMACEUTICAL CO LTD stock shows the neutral signal. See more of SANTEN PHARMACEUTICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.